GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for tryptophan 2,3-dioxygenase (Q95NN1)

Analyse AlphaFold monomer V2.0 prediction for tryptophan 2,3-dioxygenase (Q95NN1) in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
Q95NN1
Type
protein
Length
388 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x6Ed09D80e98fE15DE51C9E7a8896AbF1f2365C3e
Molecule
Tryptophan 2,3-dioxygenase
UniProt
Q95NN1
Pockets
3 · best druggability 0.78

Structure

1 distinct chain · 66% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATryptophan 2,3-dioxygenaseprotein38866% helix, 0% strandQ95NN1

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15180.780.8549empty
21720.580.8121empty
3530.340.7913empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.